Published: 30 December 2023
Author(s): Yin-Jian Yang, Fan Guo, Lu-Hong Qiu, Xi-Qi Xu, Zhi-Cheng Jing
Issue: May 2024
Section: Letter to the Editor

Endomyocardial biopsy (EMB) is important in revealing the aetiology of cardiac disorders for individuals in whom non-invasive approaches are insufficient to gather a correct diagnosis, as well as in rejection surveillance after cardiac transplantation [1,2]. Serious complications of EMB performed under the fluoroscopic guidance, which is the traditional guidance mode, can be rare in a few highly experienced medical centres [3]. Meanwhile, most medical centres have limited experience on EMB, where the serious complications are not rare [4,5].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.